Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya H Buch

Showing results (41-50 of 180) with videos related to

Pageof 18
Sort By:
BMC Musculoskeletal Disorders|August 17, 2016
Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's PhenomenonLesley-Anne Bissell, Giuseppina Abignano, Paul Emery, et al.
Rheumatology Advances in Practice|August 8, 2022
Single-centre experience of refractory rheumatoid arthritisJohn Fitton, Andrew Melville, Kamran Naraghi, et al.
Arthritis and Rheumatism|December 14, 2004
Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomideSarah J Bingham, Maya H Buch, Michael A Kerr, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 19, 2014
Collagenous colitis in systemic sclerosis: an overlooked and treatable complicationGiuseppina Abignano, Nigel Scott, Frank A Wollheim, et al.
Autoimmunity|November 28, 2024
High throughput multiplex immunoassays stratify patients according to symptom burden across the anti-Ro positive systemic autoimmune rheumatic disease spectrumSarah Dyball, Rudresh Shukla, Anastasia-Vasiliki Madenidou, et al.
Arthritis Care & Research|August 2, 2024
Barriers to, Facilitators of, and Interventions to Support Treat-to-Target Implementation in Rheumatoid Arthritis: A Systematic ReviewLaure Gossec, Louis Bessette, Ricardo M Xavier, et al.
RMD Open|July 17, 2020
Mixed results with baricitinib in biological-resistant adult-onset Still's disease and undifferentiated systemic autoinflammatory diseaseMark Kacar, John Fitton, Andrew K Gough, et al.
Trials|November 10, 2014
Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trialBara Erhayiem, Sue Pavitt, Paul Baxter, et al.
Arthritis and Rheumatism|January 11, 2005
C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanerceptMaya H Buch, Yohei Seto, Sarah J Bingham, et al.
Clinical Rheumatology|June 11, 2011
Foot health needs in people with systemic sclerosis: an audit of foot health care provisionBegonya Alcacer-Pitarch, Heidi J Siddle, Maya H Buch, et al.
Pageof 18

Showing results (41-50 of 180) with videos related to

Sort By:
Pageof 18
BMC Musculoskeletal Disorders|August 17, 2016
Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's PhenomenonLesley-Anne Bissell, Giuseppina Abignano, Paul Emery, et al.
Rheumatology Advances in Practice|August 8, 2022
Single-centre experience of refractory rheumatoid arthritisJohn Fitton, Andrew Melville, Kamran Naraghi, et al.
Arthritis and Rheumatism|December 14, 2004
Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomideSarah J Bingham, Maya H Buch, Michael A Kerr, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 19, 2014
Collagenous colitis in systemic sclerosis: an overlooked and treatable complicationGiuseppina Abignano, Nigel Scott, Frank A Wollheim, et al.
Autoimmunity|November 28, 2024
High throughput multiplex immunoassays stratify patients according to symptom burden across the anti-Ro positive systemic autoimmune rheumatic disease spectrumSarah Dyball, Rudresh Shukla, Anastasia-Vasiliki Madenidou, et al.
Arthritis Care & Research|August 2, 2024
Barriers to, Facilitators of, and Interventions to Support Treat-to-Target Implementation in Rheumatoid Arthritis: A Systematic ReviewLaure Gossec, Louis Bessette, Ricardo M Xavier, et al.
RMD Open|July 17, 2020
Mixed results with baricitinib in biological-resistant adult-onset Still's disease and undifferentiated systemic autoinflammatory diseaseMark Kacar, John Fitton, Andrew K Gough, et al.
Trials|November 10, 2014
Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trialBara Erhayiem, Sue Pavitt, Paul Baxter, et al.
Arthritis and Rheumatism|January 11, 2005
C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanerceptMaya H Buch, Yohei Seto, Sarah J Bingham, et al.
Clinical Rheumatology|June 11, 2011
Foot health needs in people with systemic sclerosis: an audit of foot health care provisionBegonya Alcacer-Pitarch, Heidi J Siddle, Maya H Buch, et al.
Pageof 18